Merck gets USFDA nod for KEYTRUDA as adjuvant treatment for non-small cell lung cancer Ruchika Sharma30 Jan 2023 9:15 AM GMTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
Merck set to remove cancer-causing chemical from top diabetes drugs Ruchika Sharma18 Jan 2023 7:45 AM GMTNew Jersey: Merck & Co has discovered how its blockbuster diabetes drugs have become contaminated with a potential carcinogen and believe it can...
Merck, Kelun-Biotech ink pact to develop seven investigational preclinical ADC for cancer treatment Ruchika Sharma25 Dec 2022 5:30 AM GMTKelun-Biotech will receive an upfront payment of $175 million from Merck.
Merck secures USFDA priority review for PADCEV with KEYTRUDA for treatment of Urothelial Cancer Ruchika Sharma22 Dec 2022 9:51 AM GMTPADCEV (enfortumab vedotin-ejfv) is a first-in-class antibody-drug conjugate (ADC) that is directed against Nectin-4, a protein located on the surface...
Centre deliberates on HPV vaccine introduction in national immunisation programme next year Ruchika Sharma19 Dec 2022 6:52 AM GMTThe government advisory panel NTAGI has also given its go-ahead for the inclusion of CERVAVAC in the public immunisation programme
Merck commences tender offer to purchase Imago BioSciences Ruchika Sharma13 Dec 2022 5:45 AM GMTRahway: Merck, known as MSD outside of the United States and Canada, has announced that it has commenced through a subsidiary, a cash tender offer to...
French drug agency under investigation over Merck thyroid drug Levothyrox Ruchika Sharma8 Dec 2022 7:00 AM GMTThe plaintiffs said Merck's decision to remove lactose from the drug to make it easier to handle had resulted in side effects such as memory loss,...
Merck hopes to patent subcutaneous version of blockbuster cancer drug Keytruda Ruchika Sharma3 Dec 2022 9:01 AM GMTMerck's patents on the subcutaneous version of Keytruda could protect that formulation until at least 2040, according to Tahir Amin, co-founder of...
Merck to purchase Imago BioSciences for USD 1.35 billion to expand blood disorder drugs portfolio Ruchika Sharma22 Nov 2022 7:00 AM GMTImago’s lead candidate bomedemstat (IMG-7289), an investigational orally available lysine-specific demethylase 1 (LSD1) inhibitor, is currently being...
Merck lifts full-year forecast as cancer immunotherapy Keytruda sales soar Ruchika Sharma29 Oct 2022 8:00 AM GMTMerck has been looking to pursue deals to protect itself from an eventual revenue loss as Keytruda patents begin to expire toward the end of the...
Merck elects Robert M Davis as new Chairman Ruchika Sharma28 Oct 2022 7:00 AM GMTDavis, who currently serves as president and chief executive officer, became Merck’s president in April 2021.
Merck under formal investigation in France over Thyroid Drug Levothyrox Ruchika Sharma20 Oct 2022 9:00 AM GMTParis: Drugmaker Merck said on Wednesday it had been placed under formal investigation by a French court for possibly issuing misleading information...
